Carlos Campoy - Net Worth and Insider Trading
Carlos Campoy Net Worth
The estimated net worth of Carlos Campoy is at least $41,664 dollars as of 2024-11-10. Carlos Campoy is the CFO of CytomX Therapeutics Inc and owns about 38,224 shares of CytomX Therapeutics Inc (CTMX) stock worth over $41,664. Details can be seen in Carlos Campoy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Carlos Campoy has not made any transactions after 2023-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Carlos Campoy
Carlos Campoy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carlos Campoy owns 3 companies in total, including CytomX Therapeutics Inc (CTMX) , Alder BioPharmaceuticals Inc (ALDR) , and Zymeworks Inc (ZYME) .
Click here to see the complete history of Carlos Campoy’s form 4 insider trades.
Insider Ownership Summary of Carlos Campoy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2023-03-16 | Chief Financial Officer |
| ALDR | Alder BioPharmaceuticals Inc | 2019-10-22 | Chief Financial Officer |
| ZYME | Zymeworks Inc | 2023-06-30 | director |
Carlos Campoy Latest Holdings Summary
Carlos Campoy currently owns a total of 1 stock. Carlos Campoy owns 38,224 shares of CytomX Therapeutics Inc (CTMX) as of March 16, 2023, with a value of $41,664.
Latest Holdings of Carlos Campoy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2023-03-16 | 38,224 | 1.09 | 41,664 |
Holding Weightings of Carlos Campoy
Carlos Campoy Form 4 Trading Tracker
According to the SEC Form 4 filings, Carlos Campoy has made a total of 2 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in CytomX Therapeutics Inc is the sale of 1,748 shares on March 16, 2023, which brought Carlos Campoy around $3,461.
Insider Trading History of Carlos Campoy
- 1
Carlos Campoy Trading Performance
Carlos Campoy Ownership Network
Ownership Network List of Carlos Campoy
Ownership Network Relation of Carlos Campoy
Carlos Campoy Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Carlos Campoy is the Chief Financial Officer of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Carlos Campoy made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Carlos Campoy Mailing Address
Above is the net worth, insider trading, and ownership report for Carlos Campoy. You might contact Carlos Campoy via mailing address: 11804 North Creek Parkway South, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
